Renal Failure (Dec 2023)

Retinopathy is associated with impaired cognition in patients undergoing peritoneal dialysis

  • Jinlan Liao,
  • Qijie Wei,
  • Yingying He,
  • Yumei Liao,
  • Zibo Xiong,
  • Qing Wang,
  • Dayong Ding,
  • Xiaoyan Huang,
  • Zuying Xiong,
  • Yonggui Wu

DOI
https://doi.org/10.1080/0886022X.2023.2258989
Journal volume & issue
Vol. 45, no. 2

Abstract

Read online

Objective Previous studies have shown a relationship between retinopathy and cognition including population with and without chronic kidney disease (CKD) but data regarding peritoneal dialysis (PD) are limited. This study aims to investigate the relationship between retinopathy and cognitive impairment in patients undergoing peritoneal dialysis (PD).Methods In this observational study, we recruited a total of 107 participants undergoing PD, consisting of 48 men and 59 women, ages ranging from 21 to 78 years. The study followed a cross-sectional design. Retinal microvascular characteristics, such as geometric changes in retinal vascular including tortuosity, fractal dimension (FD), and calibers, were assessed. Retinopathy (such as retinal hemorrhage or microaneurysms) was evaluated using digitized photographs. The Modified Mini-Mental State Examination (3MS) was performed to assess global cognitive function.Results The prevalence rates of retinal hemorrhage, microaneurysms, and retinopathy were 25%, 30%, and 43%, respectively. The mean arteriolar and venular calibers were 63.2 and 78.5 µm, respectively, and the corresponding mean tortuosity was 37.7 ± 3.6 and 37.2 ± 3.0 mm−1. The mean FD was 1.49. After adjusting for age, sex, education, mean arterial pressure, and Charlson index, a negative association was revealed between retinopathy and 3MS scores (regression coefficient: −3.71, 95% confidence interval: −7.09 to −0.33, p = 0.03).Conclusions Retinopathy, a condition common in patients undergoing PD, was associated with global cognitive impairment. These findings highlight retinopathy, can serve as a valuable primary screening tool for assessing the risk of cognitive decline.

Keywords